Rheumazentrum Ruhrgebiet, Landgrafenstrasse 15, 44652 Herne, Germany.
Ann Rheum Dis. 2011 Jun;70(6):896-904. doi: 10.1136/ard.2011.151027.
This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since 2005 and the discussion and agreement among 21 international experts, 2 patients and 2 physiotherapists in a meeting in February 2010. Each original bullet point was discussed in detail and reworded if necessary. Decisions on new recommendations were made - if necessary after voting. The strength of the recommendations (SOR) was scored on an 11-point numerical rating scale after the meeting by email. These recommendations apply to patients of all ages that fulfill the modified NY criteria for AS, independent of extra-articular manifestations, and they take into account all drug and non-drug interventions related to AS. Four overarching principles were introduced, implying that one bullet has been moved to this section. There are now 11 bullet points including 2 new ones, one related to extra-articular manifestations and one to changes in the disease course. With a mean score of 9.1 (range 8-10) the SOR was generally very good.
这是 ASAS/EULAR 关于强直性脊柱炎（AS）管理的建议的首次更新，基于原始论文、对 2005 年以来现有建议和文献的系统评价，以及 21 名国际专家、2 名患者和 2 名物理治疗师在 2010 年 2 月会议上的讨论和达成的共识。每个原始要点都进行了详细讨论，并在必要时进行了改写。对于新建议，在必要时进行了投票。会后通过电子邮件对建议的强度（SOR）进行了 11 分制的评分。这些建议适用于符合改良纽约标准的所有年龄段的 AS 患者，无论是否有关节外表现，并且考虑到与 AS 相关的所有药物和非药物干预措施。引入了四项总体原则，这意味着有一个要点已被移至本节。现在共有 11 个要点，包括 2 个新要点，一个与关节外表现有关，一个与疾病进程变化有关。SOR 的平均得分为 9.1（范围 8-10），总体非常好。
